Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
FibrinogenLinda J Stang, Lesley G Mitchell
Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
Specimen requirements for the haemostasis laboratoryLinda J Stang, Lesley G Mitchell
Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
D-dimer and fibrinogen/fibrin degradation productsLinda J Stang
Seminars in Thrombosis and Hemostasis|December 22, 2011
Outcome measures in interventional trials for prevention or treatment of venous thrombosis in the pediatric populationLesley G Mitchell, Christoph Male
Best Practice & Research. Clinical Haematology|March 17, 2009
Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatmentUlrike Nowak-Göttl, Gili Kenet, Lesley G Mitchell
British Journal of Haematology|July 20, 2016
Increased plasminogen activator inhibitor results in a hypofibrinolytic state in adolescents with obesity: in vivo and ex vivo evidenceKevin Dietrich, Geoff D C Ball, Lesley G Mitchell
Thrombosis Research|February 27, 2015
Assessing the anticoagulant effect of dabigatran in children: an in vitro studyKevin Dietrich, Linda Stang, Joanne van Ryn, et al.
Thrombosis and Haemostasis|October 14, 2025
Lymphoblasts Express Hemostatic Factors: A Mechanism for Hypercoagulability in Pediatric Acute Lymphoblastic LeukemiaGhada A Aborkhees, Kevin Dietrich, Amy J Barr, et al.
Current Opinion in Pediatrics|February 14, 2006
Thrombosis in children with malignancyLaszlo Bajzar, Anthony K Chan, Mary Patricia Massicotte, et al.
Haematologica|February 14, 2007
A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: a prospective cohort studyStefan Kuhle, Pablo Eulmesekian, Brian Kavanagh, et al.
Pageof 4